Search This Blog

Tuesday, December 11, 2018

Madrigal Pharmaceuticals initiated at B. Riley FBR


Madrigal Pharmaceuticals initiated with a Neutral at B. Riley FBR. B. Riley FBR analyst Mayank Mamtani started Madrigal Pharmaceuticals with a Neutral rating and $124 price target.
https://thefly.com/landingPageNews.php?id=2835691

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.